Advancing the global cannabis industry
The foremost source of independent data, intelligence and strategy for the cannabis industry.
Uncovering the Truth Behind The Global Cannabis Industry Slump
Issue 124 of the International Cannabis Weekly out now
The New Normal Report available for download now
The Cannabis World Map
Click each continent to view key statistics on healthcare, market size and more
Europe
Latin America
North America
Oceania
Africa
Asia
About Us
Learn MoreProhibition Partners was founded in 2017 with a mission to open up the international cannabis industry through reliable data and intelligence.
Within two years, we have become the world’s leading provider of market insights and strategic consultancy for this emerging frontier. We firmly believe that data, insights and education will unlock the societal and commercial potential of cannabis.
Our research and content teams routinely share the latest legislative developments and key trends in the industry - information that is regularly cited by political leaders, investment banks and Fortune 500 companies.
Our consultancy team works with investors, operators and regulators to identify and execute opportunities across multiple jurisdictions. We advise our private clients on licensing, regulatory and business opportunities.
Our Services
Find out moreData /
Bespoke Research, Polling, Consumer Insight, Pricing, Market Forecasting.
Intelligence /
Policy & Compliance, Regulatory Guidance, Supply / Demand.
Strategy /
Market Analysis / Entry, Business Development, Licensing, Partnerships.
ARE YOU READY TO EXPLORE OPPORTUNITY IN THE CANNABIS INDUSTRY?
News + Insights
View All03.12.2019
With stocks in the cannabis industry climbing to record highs at the end of last year, 2019 was supposed to be the most prosperous year yet for the cannabis industry....
Uncovering the Truth Behind The Global Cannabis Industry Slump
25.11.2019
The New Normal Report: Signs of the Times’ launched yesterday, in association with Protein Agency, an exploratory report documenting the rise of cannabis and CBD products across a number of...
Key insights from The New Normal Report
International Cannabis
Weekly
View All
29.11.2019
Issue
124
US FDA issues warning letters to 15 companies for illegally selling CBD products, while domestic...
22.11.2019
Issue
123
Cannabis stocks around the world rebounded after the US Congressional committee passed the MORE act,...
15.11.2019
Issue
122
Two cannabis-based medicines have been approved by the NHS in the UK while Prohibition Partners...
08.11.2019
Issue
121
Prohibition Partners releases The Global Cannabis Report, as Sadiq Khan calls for an evidence-based approach...
Press
View PageAsia’s Medicinal Cannabis Market Could Be Worth Over $US5.8 Billion by 2024
European Cannabis Industry Offers Growth Opportunities Post-Brexit, Prohibition Partners
For press inquiries, please contact us at media@prohibitionpartners.com.
What we're saying
As the end of 2019 approaches, Prohibition Partners has examined what has happened to the global cannabis industry over the past 12 months, assessing whether the market downturn should be seen as a burst bubble or an inevitable market correction.
https://prohibitionpartners.com/2019/12/03/the-truth-behind-the-global-cannabis-industry-slump/
Prohibition Partners is hosting The Institutional Capital & Cannabis Conference in Frankfurt on the 24th Feb 2020, where the market for medical cannabis is expected to grow significantly over the coming years. Early bird tickets can be bought here.
https://www.imn.org/investment-management/conference/Institutional-Capital-Cannabis-Frankfurt/Register.html
Alcohol giants @AnheuserBusch and @MolsonCoors are investing millions in cannabis-infused non-alcoholic drinks, motivated by a drop in the number of young people drinking alcohol. Discover what this means for the drinks industry in The New Normal Report. https://prohibitionpartners.com/reports/#the-new-normal-report